| MeSH term | MeSH ID | Detail |
|---|---|---|
| Synovitis, Pigmented Villonodular | D013586 | 1 associated lipids |
| Periostitis | D010522 | 1 associated lipids |
| Prosthesis Failure | D011475 | 1 associated lipids |
| Spondylarthritis | D025241 | 1 associated lipids |
| Foot Injuries | D018409 | 1 associated lipids |
| Hyperphosphatemia | D054559 | 1 associated lipids |
| Osteopetrosis | D010022 | 1 associated lipids |
| Histiocytosis, Langerhans-Cell | D006646 | 1 associated lipids |
| Jaw, Edentulous, Partially | D007576 | 1 associated lipids |
| Bone Diseases, Endocrine | D001849 | 1 associated lipids |
| Atrial Remodeling | D064752 | 1 associated lipids |
| Chondroblastoma | D002804 | 1 associated lipids |
| Tooth Resorption | D014091 | 1 associated lipids |
| Vascular Calcification | D061205 | 1 associated lipids |
| Angioid Streaks | D000793 | 1 associated lipids |
| Rupture, Spontaneous | D012422 | 1 associated lipids |
| Malocclusion, Angle Class I | D008311 | 1 associated lipids |
| Hyperostosis | D015576 | 1 associated lipids |
| Hip Dislocation | D006617 | 1 associated lipids |
| Adrenocortical Adenoma | D018246 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Zheng D et al. | The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. | 2012 | Bone | pmid:22551876 |
| Svensson M et al. | Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. | 2012 | Nephrol. Dial. Transplant. | pmid:22172725 |
| Terpos E et al. | Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis. | 2011 Nov-Dec | Clin. Exp. Rheumatol. | pmid:22032557 |
| Arikan F et al. | C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a case-control study. | 2011 Mar-Apr | Int J Oral Maxillofac Implants | pmid:21483881 |
| Crespi R et al. | Corticocancellous porcine bone in the healing of human extraction sockets: combining histomorphometry with osteoblast gene expression profiles in vivo. | 2011 Jul-Aug | Int J Oral Maxillofac Implants | pmid:21841997 |
| Franke S et al. | Advanced glycation end products affect growth and function of osteoblasts. | 2011 Jul-Aug | Clin. Exp. Rheumatol. | pmid:21906430 |
| Rezg R et al. | Inhibitors of vascular calcification as potential therapeutic targets. | 2011 Jul-Aug | J. Nephrol. | pmid:21688249 |
| Reyes-GarcÃa R et al. | [Cardiovascular disease and bone metabolism]. | 2011 Aug-Sep | Endocrinol Nutr | pmid:21775224 |
| Tsioufis C et al. | Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunction. | 2011 | Expert Opin. Ther. Targets | pmid:22136618 |
| Zhou J et al. | Expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in root resorption induced by heavy force in rats. | 2011 | J Orofac Orthop | pmid:22138776 |
| Grzibovskis M et al. | Specific signaling molecule expressions in the interradicular septum in different age groups. | 2011 | Stomatologija | pmid:22071415 |
| Chang YC and Zhao JH | Effects of platelet-rich fibrin on human periodontal ligament fibroblasts and application for periodontal infrabony defects. | 2011 | Aust Dent J | pmid:22126345 |
| Weinstein RS et al. | Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice. | 2011 | Endocrinology | pmid:21771887 |
| Lee JH et al. | Tumor necrosis factor-α converting enzyme (TACE) increases RANKL expression in osteoblasts and serves as a potential biomarker of periodontitis. | 2011 | BMB Rep | pmid:21777519 |
| Baldi D et al. | Dental implants osteogenic properties evaluated by cDNA microarrays. | 2011 | Implant Dent | pmid:21778890 |
| Kwan JS et al. | Heritability of serum osteoprotegerin. | 2011 | Ann. Hum. Genet. | pmid:21762114 |
| Ibrahim T et al. | Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients. | 2011 | Clin. Breast Cancer | pmid:21764390 |
| Yamamoto K et al. | Effects of mechanical stress on cytokine production in mandible-derived osteoblasts. | 2011 | Oral Dis | pmid:21771211 |
| Chen WJ et al. | Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men. | 2011 | Cardiovasc Diabetol | pmid:21771299 |
| Pepene CE et al. | Elevated serum receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in late-onset male hypogonadism. | 2011 | Clin Invest Med | pmid:21810381 |
| Sheng L et al. | [Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system]. | 2011 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:21812275 |
| Nakashima A et al. | Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients. | 2011 | Osteoporos Int | pmid:20812007 |
| Chen WF et al. | Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice. | 2011 | Br. J. Nutr. | pmid:20815976 |
| Zinonos I et al. | Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo. | 2011 | J. Bone Miner. Res. | pmid:20818644 |
| Loncar G et al. | Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure. | 2011 | J. Endocrinol. Invest. | pmid:20820131 |
| Gradosova I et al. | The role of atorvastatin in bone metabolism in male albino Wistar rats. | 2011 | Pharmazie | pmid:21901984 |
| Straface G et al. | Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability. | 2011 | Stroke | pmid:21903966 |
| Tripathi A et al. | Bisphosphonate therapy for skeletal malignancies and metastases: impact on jaw bones and prosthodontic concerns. | 2011 | J Prosthodont | pmid:21883630 |
| Mohamed GB and Abdel-Latif EA | Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome. | 2011 | Saudi J Kidney Dis Transpl | pmid:21912025 |
| Lommi JI et al. | High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification. | 2011 | Atherosclerosis | pmid:21917259 |
| Embree M et al. | Role of subchondral bone during early-stage experimental TMJ osteoarthritis. | 2011 | J. Dent. Res. | pmid:21917603 |
| D'Amelio P et al. | Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures. | 2011 | Osteoporos Int | pmid:21116815 |
| Giner M et al. | Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis. | 2011 | Eur. J. Pharmacol. | pmid:21050847 |
| To M et al. | Osteoprotegerin in sputum is a potential biomarker in COPD. | 2011 | Chest | pmid:21127170 |
| Witasp A et al. | Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease. | 2011 | Eur. J. Clin. Invest. | pmid:21128937 |
| Khoshniat S et al. | Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/2 pathway is modulated by calcium. | 2011 | Bone | pmid:21147284 |
| Gulseren A et al. | Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin. | 2011 | Panminerva Med | pmid:21659972 |
| Corallini F et al. | Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. | 2011 | J. Cell. Physiol. | pmid:21660951 |
| Roshandel D et al. | Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men. | 2011 | Calcif. Tissue Int. | pmid:21964949 |
| Costa-Rodrigues J and Fernandes MH | Paracrine-mediated differentiation and activation of human haematopoietic osteoclast precursor cells by skin and gingival fibroblasts. | 2011 | Cell Prolif. | pmid:21535267 |
| Davenport C et al. | Identifying coronary artery disease in men with type 2 diabetes: osteoprotegerin, pulse wave velocity, and other biomarkers of cardiovascular risk. | 2011 | J. Hypertens. | pmid:21970938 |
| Lee YS and Choi EM | Apocynin stimulates osteoblast differentiation and inhibits bone-resorbing mediators in MC3T3-E1 cells. | 2011 | Cell. Immunol. | pmid:21683946 |
| Hossein-nezhad A et al. | The influence of folic acid supplementation on maternal and fetal bone turnover. | 2011 | J. Bone Miner. Metab. | pmid:20602129 |
| Miyamoto K et al. | Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. | 2011 | J. Exp. Med. | pmid:22006978 |
| Schoppet M et al. | Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21371424 |
| Quemerais-Durieu MA et al. | [Therapeutic innovation in osteoporosis (antisclerostin antibody and denosumab)]. | 2011 | Ann. Endocrinol. (Paris) | pmid:22008272 |
| Pobeha P et al. | Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. | 2011 | Bone | pmid:21376149 |
| Koo HM et al. | Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients. | 2011 | Atherosclerosis | pmid:22015178 |
| Krause U et al. | Assays of osteogenic differentiation by cultured human mesenchymal stem cells. | 2011 | Methods Mol. Biol. | pmid:21431522 |
| Clemens TL and Karsenty G | The osteoblast: an insulin target cell controlling glucose homeostasis. | 2011 | J. Bone Miner. Res. | pmid:21433069 |
| Galliera E et al. | Circulating OPG levels are reduced following infliximab treatment and correlate with CRP levels: is serum OPG a potential marker of IBD disease activity? | 2011 | Inflamm. Bowel Dis. | pmid:21433226 |
| Cao H et al. | Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation. | 2011 | Circ. J. | pmid:22001292 |
| Hou L et al. | Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts. | 2011 | Acta Vet. Scand. | pmid:21435269 |
| Baloul SS et al. | Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. | 2011 | Am J Orthod Dentofacial Orthop | pmid:21435543 |
| Ferrari-Lacraz S and Ferrari S | Do RANKL inhibitors (denosumab) affect inflammation and immunity? | 2011 | Osteoporos Int | pmid:20571772 |
| Siomou E et al. | Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease. | 2011 | Pediatr. Nephrol. | pmid:21479768 |
| Sexton WM et al. | Salivary biomarkers of periodontal disease in response to treatment. | 2011 | J. Clin. Periodontol. | pmid:21480939 |
| Mödder UI et al. | Regulation of circulating sclerostin levels by sex steroids in women and in men. | 2011 | J. Bone Miner. Res. | pmid:20499362 |
| Cordeiro MM et al. | Primary teeth show less protecting factors against root resorption. | 2011 | Int J Paediatr Dent | pmid:21481035 |
| Mainini G et al. | Serum osteoprotegerin correlates with age and bone mass in postmenopausal, but not in fertile age women. | 2011 | Clin Exp Obstet Gynecol | pmid:22268274 |
| Kaneuji T et al. | Mechanisms involved in regulation of osteoclastic differentiation by mechanical stress-loaded osteoblasts. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21459078 |
| Luvizuto ER et al. | Raloxifene therapy inhibits osteoclastogenesis during the alveolar healing process in rats. | 2011 | Arch. Oral Biol. | pmid:21536255 |
| Riksen EA et al. | Human osteoblastic cells discriminate between 20-kDa amelogenin isoforms. | 2011 | Eur. J. Oral Sci. | pmid:22243268 |
| Al-Dujaili SA et al. | Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro. | 2011 | J. Cell. Biochem. | pmid:21538477 |
| Stępień E et al. | Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals. | 2011 | Clin. Biochem. | pmid:21539822 |
| Yang Z et al. | [Effects of negative pressure on osteogenesis in human bone marrow-derived stroma cells cultured in vitro]. | 2011 | Zhongguo Gu Shang | pmid:22276514 |
| Zheng Y et al. | Vitamin D deficiency promotes prostate cancer growth in bone. | 2011 | Prostate | pmid:21541977 |
| Park JS et al. | Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus. | 2011 | Eur. J. Endocrinol. | pmid:20961967 |
| Karosi T et al. | Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity. | 2011 | Eur Arch Otorhinolaryngol | pmid:20963600 |
| Halade GV et al. | Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. | 2011 | Exp. Gerontol. | pmid:20923699 |
| Mitsuhashi M et al. | Effects of HSP70 on the compression force-induced TNF-α and RANKL expression in human periodontal ligament cells. | 2011 | Inflamm. Res. | pmid:20924639 |
| Huang CH et al. | Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis. | 2011 | Rheumatology (Oxford) | pmid:20974615 |
| WaluÅ›-Miarka M et al. | Osteoprotegerin is associated with markers of atherosclerosis and body fat mass in type 2 diabetes patients. | 2011 | Int. J. Cardiol. | pmid:21255853 |
| Saito CT et al. | Effect of low-level laser therapy on the healing process after tooth replantation: a histomorphometrical and immunohistochemical analysis. | 2011 | Dent Traumatol | pmid:21244626 |
| Erkol A et al. | Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention. | 2011 | Am. J. Cardiol. | pmid:21247537 |
| Bai P et al. | Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. | 2011 | Respir. Res. | pmid:22176920 |
| Sobue T et al. | Murine TMJ loading causes increased proliferation and chondrocyte maturation. | 2011 | J. Dent. Res. | pmid:21248355 |
| Ribeiro FV et al. | Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis. | 2011 | J. Periodontol. | pmid:21284550 |
| Vik A et al. | Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study. | 2011 | J. Thromb. Haemost. | pmid:21284802 |
| Piedra M et al. | "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density". | 2011 | BMC Med. Genet. | pmid:22185226 |
| Hasegawa T et al. | [Animal models for bone and joint disease. Bone disease of osteoprotegerin deficient mouse]. | 2011 | Clin Calcium | pmid:21289415 |
| Qu Z et al. | Effect of enamel matrix derivative on proliferation and differentiation of osteoblast cells grown on the titanium implant surface. | 2011 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:21232997 |
| Rauch A et al. | An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. | 2011 | FASEB J. | pmid:21233489 |
| Caetano-Lopes J et al. | Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing. | 2011 | PLoS ONE | pmid:21347301 |
| Assmann G et al. | Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: a case-control study. | 2011 | J. Dermatol. | pmid:21352301 |
| Audo R et al. | Mechanisms and clinical relevance of TRAIL-triggered responses in the synovial fibroblasts of patients with rheumatoid arthritis. | 2011 | Arthritis Rheum. | pmid:21305500 |
| Alexander KA et al. | Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. | 2011 | J. Bone Miner. Res. | pmid:21305607 |
| Jabbar S et al. | Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis. | 2011 | J. Clin. Pathol. | pmid:21307155 |
| Maïmoun L et al. | In peripubertal girls, artistic gymnastics improves areal bone mineral density and femoral bone geometry without affecting serum OPG/RANKL levels. | 2011 | Osteoporos Int | pmid:21359671 |
| Polzer K et al. | Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis. | 2011 | Arthritis Rheum. | pmid:21360496 |
| Oshita K et al. | Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. | 2011 | Arthritis Rheum. | pmid:21360521 |
| Wang SY et al. | Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis. | 2011 | J. Rheumatol. | pmid:21362762 |
| Ignatius A et al. | Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β. | 2011 | J. Cell. Biochem. | pmid:21598302 |
| Preshaw PM and Taylor JJ | How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? | 2011 | J. Clin. Periodontol. | pmid:21323705 |
| Sun CX et al. | [Patterns of osteoprotegerin or nuclear factor kappa B ligand gene expression in the treatment of bone defect with bone marrow stem cell transplantation and low-frequency vibration]. | 2011 | Zhonghua Yi Xue Za Zhi | pmid:21600122 |
| Basu R et al. | Effects of physiological variations in circulating insulin levels on bone turnover in humans. | 2011 | J. Clin. Endocrinol. Metab. | pmid:21325461 |
| Liu ZF et al. | [Effect of ultrasound on osteoprotegerin and receptor activator nuclear factor kappaB ligand expression during root resorption in rats]. | 2011 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:21602131 |
| Blázquez-Medela AM et al. | Osteoprotegerin and diabetes-associated pathologies. | 2011 | Curr. Mol. Med. | pmid:21568931 |
| Peng S et al. | Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption. | 2011 | J. Bone Miner. Res. | pmid:21611968 |
| Mai QG et al. | Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. | 2011 | J. Cell. Biochem. | pmid:21618594 |